Nobivac NXT HCPChFeLV | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

5,195 results for “Nobivac NXT HCPChFeLV”

Trials

View all 3982 →

OverStitch NXT Endoscopic Suture System

136 participants · First posted Dec 11, 2025

Not yet recruiting

Immediate vs Delayed Postpartum Implanon-NXT

90 participants · First posted Jun 4, 2026

T-DOC® NXT Clinical Investigation

20 participants · First posted Aug 3, 2018

Drugs

View all 514 →

NXT-10796

NXT-1021

NXT-182

Organizations

View all 16 →

AnteoTech Ltd

Australia

Nobias Therapeutics, Inc.

United States

NMT Medical

Canada

News

View all 683 →

EMA Recommends First Veterinary Vaccine Using Self-Amplifying RNA Technology for Cat Protection

Elutia Appoints Pete Ligotti as CCO to Lead NXT-41x Commercial Launch in $1.5B Breast Reconstruction Market

Boston Scientific Acquires Elutia's BioEnvelope Business for $88 Million, Fueling Breast Reconstruction Pipeline

Page 1 of 520